Literature DB >> 25564395

Reliability and feasibility of longitudinal AFI global and segmental strain compared with 2D left ventricular volumes and ejection fraction: intra- and inter-operator, test-retest, and inter-cycle reproducibility.

Paolo Barbier1, Oana Mirea2, Claudia Cefalù2, Anna Maltagliati2, Gabriele Savioli3, Marco Guglielmo2.   

Abstract

AIMS: Echocardiographic evaluation of 2D longitudinal peak systolic strain (LPSS) can detect initial impairment of left ventricular (LV) function in heart disease. Global LPSS (GLPSS) variability has been assessed in small groups and segmental LPSS has not been determined. We compared variability of GLPSS and segmental LPSS with that of 2D LV volumes and ejection fraction (EF) in patients with and without heart diseases. METHODS AND
RESULTS: 2D speckle tracking analysis was performed on LV apical views using automated function imaging (AFI) software (GE Healthcare). Intra-operator, inter-cycle, and test-retest variability (bias and CR, coefficient of reproducibility; MPE, mean percent error; CV, coefficient of variation) was assessed for GLPSS, 18 segments of LPSS, and LV volumes and EF in 40 patients (720 segments), and inter-operator variability in 250 patients (4500 segments). Feasibility of segmental tracking was 93.1%. Variability of GLPSS increased from a minimum intra-operator CV = -2.6% to a maximum test-retest CV = -5.4% and was lower than that assessed for volumes and EF. Segmental intra-operator LPSS CV ranged from -5.6 to -14.7%, and test-retest from -8 to -22%, and was at worst similar to variability of end-systolic volume. In the 8.3% of segments with the highest variability, this was related to suboptimal imaging, minor changes in scan angulation, and insufficient ROI width.
CONCLUSION: Overall, reproducibility of GLPSS is excellent and superior to that of 2D EF, whereas segmental LPSS reproducibility is good and similar to that of LV volumes. Both are suitable for diagnosis and follow-up of LV global and regional systolic function. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  echocardiography; ejection fraction; reproducibility; strain; ventricular; volumes

Mesh:

Year:  2015        PMID: 25564395     DOI: 10.1093/ehjci/jeu274

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  15 in total

1.  Reliability and feasibility of automated function imaging for quantification in patients with left ventricular dilation: comparison with cardiac magnetic resonance.

Authors:  Yefen Chen; Wei Hua; Wenbo Yang; Zhongwei Shi; Yuehua Fang
Journal:  Int J Cardiovasc Imaging       Date:  2022-01-03       Impact factor: 2.357

2.  Evaluation of Cardiovascular Toxicity Associated with Treatments Containing Proteasome Inhibitors in Multiple Myeloma Therapy.

Authors:  Andrea Iannaccone; G Bruno; A Ravera; F Gay; M Salvini; S Bringhen; L Sabia; E Avenatti; F Veglio; A Milan
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-03-26

3.  Regional Mechanical Changes Assessed by 2D Speckle-Tracking Longitudinal Strain do not Parallel Electrical Post-Pacing Cardiac Memory.

Authors:  Suran Maria-Claudia-Berenice; Margulescu Andrei-Dumitru; Bruja Ramona; Siliste Calin; Vinereanu Dragos
Journal:  Maedica (Bucur)       Date:  2018-09

4.  Association of peripheral nerve conduction in diabetic neuropathy with subclinical left ventricular systolic dysfunction.

Authors:  Yasuhide Mochizuki; Hidekazu Tanaka; Kensuke Matsumoto; Hiroyuki Sano; Hiromi Toki; Hiroyuki Shimoura; Junichi Ooka; Takuma Sawa; Yoshiki Motoji; Keiko Ryo; Yushi Hirota; Wataru Ogawa; Ken-ichi Hirata
Journal:  Cardiovasc Diabetol       Date:  2015-05-07       Impact factor: 9.951

5.  Impact of image quality on reliability of the measurements of left ventricular systolic function and global longitudinal strain in 2D echocardiography.

Authors:  Yasufumi Nagata; Yuichiro Kado; Takeshi Onoue; Kyoko Otani; Akemi Nakazono; Yutaka Otsuji; Masaaki Takeuchi
Journal:  Echo Res Pract       Date:  2018-02-05

6.  Myocardial strain imaging: review of general principles, validation, and sources of discrepancies.

Authors:  M S Amzulescu; M De Craene; H Langet; A Pasquet; D Vancraeynest; A C Pouleur; J L Vanoverschelde; B L Gerber
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2019-06-01       Impact factor: 6.875

7.  Deformation imaging to assess global and regional effects of cardiac regenerative therapy in ischaemic heart disease: A systematic review.

Authors:  Bas R van Klarenbosch; Steven A J Chamuleau; Arco J Teske
Journal:  J Tissue Eng Regen Med       Date:  2019-09-01       Impact factor: 3.963

8.  Left ventricular global longitudinal strain in predicting CRT response: one more J-shaped curve in medicine.

Authors:  Michal Orszulak; Artur Filipecki; Wojciech Wrobel; Adrianna Berger-Kucza; Witold Orszulak; Dagmara Urbanczyk-Swic; Wojciech Kwasniewski; Katarzyna Mizia-Stec
Journal:  Heart Vessels       Date:  2021-02-06       Impact factor: 2.037

9.  Test-retest reliability of new and conventional echocardiographic parameters of left ventricular systolic function.

Authors:  Tomasz Baron; Lars Berglund; Eva-Maria Hedin; Frank A Flachskampf
Journal:  Clin Res Cardiol       Date:  2018-10-27       Impact factor: 5.460

10.  Effect of SAcubitril/Valsartan on left vEntricular ejection fraction and on the potential indication for Implantable Cardioverter Defibrillator in primary prevention: the SAVE-ICD study.

Authors:  Federico Guerra; Ernesto Ammendola; Matteo Ziacchi; Vittorio Aspromonte; Pier Luigi Pellegrino; Giuseppe Del Giorno; Gabriele Dell'Era; Lorenzo Pimpini; Francesco Santoro; Roberto Floris; Giulia Stronati; Gerardo Nigro; Pasquale Paolisso; Alessandro Guido; Giampiero Maglia; Natale Daniele Brunetti; Angelo Carbone; Miriam Gravellone; Roberto Antonicelli; Michele Cannone; Michele Accogli; Antonio Dello Russo; Pietro Palmisano
Journal:  Eur J Clin Pharmacol       Date:  2021-07-19       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.